Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease

Nonalcoholic fatty liver disease (NAFLD) is considered a critical hepatic manifestation of metabolic syndrome. Berberine (BBR) exerts anti-hyperglycemic and anti-dyslipidemic effects and can also ameliorate NA...

Source: BMC Endocrine Disorders - February 28, 2017 Category: Endocrinology Authors: Li Zhao, Zhen Cang, Honglin Sun, Xiaomin Nie, Ningjian Wang and Yingli Lu Source Type: research